Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
2.010
+0.090 (4.69%)
Aug 12, 2025, 4:00 PM - Market closed
Satixfy Communications Employees
Fortress Biotech had 101 employees as of December 31, 2024. The number of employees decreased by 85 or -45.70% compared to the previous year.
Employees
101
Change (1Y)
-85
Growth (1Y)
-45.70%
Revenue / Employee
$572,119
Profits / Employee
-$502,436
Market Cap
59.44M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 101 | -85 | -45.70% |
Dec 31, 2023 | 186 | -1 | -0.53% |
Dec 31, 2022 | 187 | 14 | 8.09% |
Dec 31, 2021 | 173 | 62 | 55.86% |
Dec 31, 2020 | 111 | 18 | 19.35% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
FBIO News
- 14 hours ago - Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 days ago - Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 - GlobeNewsWire
- 7 days ago - Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 - GlobeNewsWire
- 4 weeks ago - Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™ - GlobeNewsWire
- 7 weeks ago - Journey Medical to Join Russell 2000® and Russell 3000® Indexes - GlobeNewsWire
- 7 weeks ago - Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference - GlobeNewsWire
- 2 months ago - Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - GlobeNewsWire
- 2 months ago - Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - GlobeNewsWire